TheJobsMapAbout Mireca Medicines GmbH
Developing cGMP analog drug products - Mireca Medicines GmbH, Tübingen, is an expanding, preclinical stage company pioneering the development of proprietary cyclic guanosine monophosphate (cGMP)-analogs and drug delivery technologies to treat diseases caused by a dysregulation of cGMP, affecting protein kinase G (PKG). Mireca’s lead program focusses on the inhibition of cGMP signaling for neuroprotection and has obtained positive preclinical data for inherited retinal diseases (IRD) like Retinitis Pigmentosa (RP), Leber’s Congenital Amaurosis, and Stargardt’s disease.
- Founded
- 2017
- Employees
- 1 to 10
- Headquarters
- Germany
Leadership
The top of Mireca Medicines GmbH's org chart, with how many people report into each leader.
Barbara Brunnhuber
CEO
Jobs at Mireca Medicines GmbH
No open positions right now. Explore more companies on TheJobsMap.